Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer
Clinical trial NCT01126736 · COMPLETED
Trial details
- NCT number
- NCT01126736
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-10
- Primary completion
- 2012-12-31
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.